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Wild-type and HIF1α−/− MEF cells were used to determine the role of HIF1α in cadmium-induced toxicity. Cadmium treatment
didnotaﬀectHIF1-mediatedtranscriptionbutledtocaspaseactivationandapoptoticcelldeathinwild-typeandHIF1α−/−cells.
Cadmium-induced cell death, however, was signiﬁcantly higher in HIF1α − /− cells as compared to their wild-type counterparts.
Increased cell death in the HIF1α − /− cells was correlated with lower metallothionein protein, elevated levels of reactive oxygen
species, and decreased superoxide dismutase enzyme activity. The total and oxidized glutathione levels, and, correspondingly, lipid
peroxidationlevelswereelevatedinthenullcellscomparedtowild-typecells,indicatingincreasedantioxidantdemandandgreater
oxidative stress. Overall, the results suggest that basal levels of HIF1α play a protective role against cadmium-induced cytotoxicity
in mouse embryonic ﬁbroblasts by maintaining metallothionein and antioxidant activity levels.
1.Introduction
Most organisms require an aerobic environment for survival
and have a well-developed signaling system to adapt to
ﬂuctuations in oxygen availability. Hypoxia inducible factor
1α (HIF1α) is a protein that plays a role in the cellular and
physiological response to decreases in oxygen concentrations
(i.e., hypoxia). HIF1α is a multi-domain transcription factor
with an oxygen-dependent degradation domain (ODD), a
transcriptional activation domain (TAD), and basic Helix-
Loop-Helix (bHLH) and Per-Arnt-Sim (PAS) domain [1].
Under normal oxygen or normoxic conditions, HIF1α is
constitutively expressed but undergoes rapid proteolysis
[2]. During hypoxia, HIF1α escapes degradation, translo-
cates into the nucleus, forms a heterodimer with the aryl
hydrocarbon nuclear translocator (ARNT), and regulates the
transcription of a large number of target genes by binding to
hypoxia response elements (HRE) in their regulatory regions
[3–5]. These genes are involved in the adaptive response,
including those associated with oxygen transport, vascular
development, glycolysis, angiogenesis, and others [6].
HIF1α proteinfunctionisregulatedatthelevelofprotein
stability and TAD activity by two diﬀerent hydroxylases.
An asparagine residue within the TAD is modiﬁed by
the enzyme, Factor Inhibiting HIF1 (FIH), preventing it
from interacting with p300 when oxygen is present [7].
HIF1α protein stability is regulated by the prolyl hydrox-
ylase domain containing proteins (PHDs), which modify
conserved residues in the ODD of the transcription factor
under normoxia. This hydroxylation targets HIF1α for
ubiquitination via a Von-Hippel-Lindau (VHL) protein-
dependent process, and it is subsequently degraded by the
26S proteasome machinery [8–10] .T h eP H D sa r eo x y g e n -
and iron-dependent dioxygenases and are inhibited by
hypoxia, iron chelators, and certain divalent metals, such
as cobalt and nickel [2, 11]. The PHDs contain nonheme
iron at their active site and require ascorbate as a cofactor
for maintaining iron in the reduced state for catalytic2 Journal of Toxicology
activity [9]. Divalent metals, such as nickel, manganese, and
cobalt, can compete for iron at the catalytic site, rendering
the enzyme inactive. Though other mechanisms have been
proposed for metal-induced hypoxia signaling, it is widely
accepted that certain divalent metals are capable of acting as
hypoxia mimics in terms of inducing HIF1α stability [9, 11–
13].
This interplay between metal exposure and the hypoxic
signaling pathway suggests a potential role for HIF1α in
regulating an adaptive response against cadmium-induced
oxidative stress. Cadmium is a divalent metal with strong
environmental ramiﬁcations. Natural processes, such as
erosion of rocks, volcanic eruptions, and forest ﬁres, as
well as, the burning of fossil fuels and use of sewage
sludge as fertilizer, can result in an increased exposure risk
to humans. Human exposure results from cigarette smoking
and the consumption of contaminated food and water [14].
Exposure to cadmium leads to a broad range of toxicities,
including osteoporosis, liver and kidney dysfunction, and
cancer. The ability of cadmium to induce this variety of
toxicities is most likely related to its ability to produce oxida-
tive stress through the depletion of cellular antioxidant pool,
speciﬁcally glutathione, and the resulting lipid peroxidation
[15–17]. Very little is known, however, about the role of
HIF1α in regulating cadmium-induced cell stress.
In the present research, the role of HIF1α in mediating
the toxic eﬀects of cadmium exposure was studied using two
genetically matched strains of mouse embryonic ﬁbroblasts
(MEFs). Our results show that the absence of HIF1α leads to
increasedsusceptibilitytocadmium-inducedtoxicity.Lossof
HIF1α alters the cell’s ability to maintain the levels of metal
transcription factor-1 (MTF-1) and metallothionein, and
this decrease correlates with increased cadmium-induced
toxicity. The ﬁndings also indicate that the basal expression
of HIF1α under normoxia plays a crucial role in maintaining
the levels of cellular antioxidants such as SOD1, SOD2, and
glutathione. Finally, the results suggest that HIF1α-mediated
cell signaling plays a key role in protecting cells against the
oxidative stress produced by cadmium exposure.
2.MaterialsandMethods
2.1. Materials. Tissue culture media and supplements were
obtained from Invitrogen, Inc. with the exception of cosmic
calf serum which was obtained from Hyclone. Oligonu-
cleotides were synthesized by the Macromolecular Facility,
Michigan State University, East Lansing, MI. SYBR Green
real-timePCRreagentswerepurchasedfromAppliedBiosys-
tems, CA. All other chemicals were reagent grade and
obtained from Sigma Chemical Company, MO.
2.2. Cell Culture and Toxicity Assay. Wild-type and
HIF1α−/− mouse embryonic ﬁbroblast (MEF) cell lines
were generated in the lab of Dr. Randall Johnson (UCSD,
San Diego) [18]. Brieﬂy, ﬁbroblasts were isolated from
conditional null HIF1α mouse embryos. These mice
contained loxP sites ﬂanking exon2 of the HIF1α gene.
The cells were immortalized and transformed by stable
transfection of SV40 large T-antigen and H-ras oncogene,
respectively. These immortalized cells were divided, and
wild-type and HIF1α−/− cells were generated by infecting
the cells with adenovirus carrying β-galactosidase or
cre recombinase, respectively. MEFs were maintained in
Dulbeco’s Modiﬁed Eagle Medium (DMEM) with 10%
heat inactivated FBS, penicillin-streptomycin (10U/mL),
nonessential amino acid (0.1mM), L-glutamine (2mM) and
Hepes Buﬀer, pH 7.0 (10mM). Cells were grown in 96
well plates and treated with 0, 1, 2, 5, and 10μM CdCl2
for 72 hours. For ROS scavenger protection studies, cells
were treated with CdCl2 (5 or 10μM) alone or in the
presence of various reactive oxygen species scavengers,
such as reduced glutathione (1mM), oxidized glutathione
(1mM), melatonin (0.5mM), N-acetyl cysteine (10mM),
or ascorbic acid (0.5mM) where indicated. Toxicity assays
were performed by replacing the treatment media with
100μL of media containing 3-(4,5-dimethylthiazolyl-
2)-2,5-diphenyltetrazolium bromide (MTT, 0.5mg/mL),
then incubated for 4 hours. Media was then removed by
aspiration. The formazan crystals formed were solubilized
by adding 200μL of solvent (1:1 DMSO:ethanol 1:1
v/v) followed by agitation for 15 minutes. Optical density
(OD) measurements were taken at 550 and 630nm and the
diﬀerence in OD relative to untreated controls was taken as
a measure of cell viability [19].
2.3. Protein Extraction and Western Blotting. Wild-type and
HIF1α−/− cells were grown in normal medium, or in
the presence of 150μMC o C l 2,or 1, 5 or 10μM CdCl2,
or 150μMC o C l 2 and 5μM CdCl2, and protein extracts
were prepared. For HIF1α western blot analysis, nuclear
protein was extracted as previously described [20]. Brieﬂy,
cells were washed twice with cold (4◦C) PBS and manually
removed by scraping in PBS and pelleted by centrifugation.
Cytoplasmic proteins were removed by disrupting the cells
in a dounce homogenizer in lysing Buﬀer A (10mM Tris
(pH7.5), 1.5mM MgCl2, 10mM KCl, freshly supplemented
w i t h1 m MD T T ,2 m MP M S F ,2 m MN a 3VO4,a n d1
protease inhibitor cocktail tablet per 7mL buﬀer (MiniTab,
Roche)).Nucleiwerecollectedbycentrifugationandlysedby
resuspension in Buﬀer C (0.42M KCl, 20mM Tris (pH7.5),
20% glycerol, 1.5mM MgCl2, freshly supplemented with
1mM DTT, 2mM PMSF, 2mM Na3VO4,a n d1p r o t e a s e
inhibitor cocktail tablet per 7mL buﬀer (MiniTab, Roche)),
followed by rotating at 4◦C for one hour. Lysate was cleared
by centrifugation at 20,000 × g for 20 minutes. For BNIP3,
SOD1, SOD2, MT-1/2, and MTF-1 Westerns, total cell lysate
was used. Brieﬂy, cells were washed with cold PBS (4◦C)
and removed from the surface by scraping in cold PBS and
collected by centrifugation. Soluble proteins were extracted
with cell lysis buﬀer (25mM HEPES, pH 7.6, 2mM EDTA,
10% glycerol, 1mM PMSF, and protease inhibitor cocktail
from Roche) by sonication (5secs., 4◦C). Insoluble material
was removed by centrifugation (15,000 × g, 20min.) and
protein concentrations were determined using Bradford
assay kit (Bio-Rad) via manufacturer’s instructions. An
equal amount of protein was separated by SDS-PAGE,
and Western blotting was performed with anti-HIF1α orJournal of Toxicology 3
Metallothionein 1/2 (Novus Biologicals, CO., NB-100-479
or NB600-1039) or BNip3 or β-actin (Sigma) or SOD1 or
SOD2 or MTF-1-speciﬁc antibodies (Santa Cruz Biotech, sc-
11407 or sc-18503 or H-300) using ECL chemiluminescent
detectionkit(AmershamPharmacia).ForMT-1/2adiﬀerent
Western blot procedure was used. Total protein (50μg)
was separated on a 20% SDS-PAGE and transferred to
nitrocellulose membrane. After the transfer, the hydrophilic
MT-1/2 was immobilized to the membrane by treating with
2.5% glutaraldehyde as previously described [21]. The blots
were probed with MT-1/2-speciﬁc antibody.
2.4. RNA Extraction and Reverse Transcription. RNA extrac-
tion was performed using TriZol reagent (Invitrogen) via
manufacturer’s instructions. Brieﬂy, cells were treated for the
speciﬁc duration and washed in 1X PBS (4◦C). Cells were
removed by scraping in the presence of TriZol reagent. Phase
separation was accomplished by the addition of chloroform
and centrifugation (18,000 × g, 15min). RNA was precip-
itated using isopropanol and quantiﬁed using a Nano-drop
ND-1000 spectrophotometer (Thermo Scientiﬁc, Wilming-
ton, DE). Total RNA (1μg) was reverse-transcribed with
Superscript II RNase H- Reverse Transcriptase (Invitrogen)
via manufacturer’s instructions.
2.5.Real-TimeQuantitativePCRAnalysis. Themeasurement
of BNIP3, SOD1, and SOD2 mRNA levels was performed
via real-time PCR technology using ABI SYBR Green core
reagent kit. Primers were designed using the web-based
application Primer3, biasing towards the 3  end of the
transcript and spanning an intron-exon junction (Table 1)
[22]. All of the assays were performed on an ABI 7700 under
standard thermal cycling parameters: 95◦C for 10min, 40
cycles of 95◦C for 15 seconds, and 60◦C for 60 seconds. The
murine hypoxanthine guanine phosphoribosyl transferase
(HPRT) gene was used as a control and was shown to be
unaﬀected by any treatment used. Standard curves were used
to calculate the relative abundance of mRNA from the Ct
values.
2.6. Determination of ROS Levels. Cells were left untreated
or treated with 10μM CdCl2 for 24 hours or 2mM H2O2
for 1 hour. Cell were trypsinized, pelleted, and treated with
5μMCM-H 2DCFDA(MolecularProbes,OR)for30minutes
in serum-free media. Cells were washed and resuspended
in PBS, supplemented with 10% cosmic calf serum, and
analyzed on a BD FACSDiva ﬂow cytometer. Fluorescence
intensity, (490nm excitation and 520nm emission) of 1 ×
104 cells for each sample, was measured and experiments
were performed in duplicate.
2.7. Determination of Superoxide Dismutase Activity. Total
cellular superoxide dismutase activity was measured using
superoxide dismutase assay (Cayman Chemicals, MI) as per
manufacturer’s description. Brieﬂy, treated cells were har-
vested, pelleted, and lysed by sonication in buﬀer containing
20mM Hepes (pH 7.2), 1mM EGTA, 210mM mannitol and
70mM sucrose. Supernatant was collected after centrifuging
at 1,500 × g for 5 minutes, and an aliquot was used for
performing the superoxide dismutase assay. Enzyme activity
was quantiﬁed using a standard curve. The results were
normalized to total protein levels.
2.8. Determination of Glutathione Levels. Total glutathione
levels were determined using a spectrophotometric assay
(Cayman Chemicals, Ann Arbor, MI) as per manufacturer’s
instructions. Brieﬂy, treated cells were harvested by scraping
in cold (4◦C) PBS and pelleted by centrifugation (1,000
× g, 5 minutes). Cells were sonicated in 1X MES buﬀer,
and insoluble material was removed by centrifugation (5,000
× g, 5 minutes). The supernatant was deproteinated by
the addition of an equal volume of 10% metaphosphoric
acid and neutralized by adding 0.2mM triethanolamine.
Glutathione concentration was determined by performing a
coupled kinetic assay in which the reduction of glutathione
is coupled to the conversion of the colorless tetrazolium salt
into formazan, then measured spectrophotometrically. The
levelsofreducedglutathioneweredeterminedbytreatingthe
samples with 2-vinylpyridine (10mM) for 1 hour at room
temperature before performing the assay. The results were
normalized to total protein levels.
2.9. Determination of Lipid Peroxidation of Levels. Malondi-
aldehyde (MDA) levels, indicative of lipid peroxidation, were
determined using TBARS assay kit (Cayman Chemicals, Ann
Arbor,MI)aspermanufacturer’sinstructions.Brieﬂy,2×107
cells were harvested in PBS after being treated with CdCl2
(5μM)for24hoursorH2O2 (2mM)for4hours.Cellextract
was prepared by sonication. The samples and standards were
reacted with thiobarbituric acid by heating in a boiling water
bath for 1 hour, and optical density was measured at 540nm.
The MDA levels in the samples were determined using the
standard curve. The results were normalized to total protein
levels.
2.10. Statistics. Statistical analysis was performed between
treated and untreated samples in each experiment using the
t-test (two tailed, unequal variance, P ≤ 0.05) with the help
of Microsoft Excel software.
3. Results
3.1. HIF1α −/− MEFs Show Greater Susceptibility to CdCl2.
Cadmium-induced cytotoxicity was determined in wild type
and HIF1α −/− mouse embryonic ﬁbroblast (MEFs) using
an MTT assay. Both cell types were exposed to varying
doses of CdCl2 (Figure 1(a)) for 72 hours. Wild-type and
HIF1α −/− cell lines displayed a dose-dependent decrease in
viability following cadmium treatment. Cadmium chloride
treatment, however, caused signiﬁcantly greater cytotoxicity
(P<0.05) in the HIF1α −/− cells compared to the wild-
type cells at the 5 and 10μM dose. To verify the timing
of cadmium-induced toxicity, WT and HIF1α −/− were
exposed to the metal (5μM) for various times. There was
a signiﬁcant decrease in viability of the HIF1α −/− cells
following 24 hours of cadmium (5μM) as compared to4 Journal of Toxicology
Table 1: qRT-PCR primers.
Gene Accession Forward Reverse
HPRT NM 013556 AAGCCTAAGATGAGCGCAAG TTACTAGGCAGATGGCCACA
BNip3 NM 009760 GGCGTCTGACAACTTCCACT AACACCCAAGGACCATGCTA
SOD1 BC002066 GAGACCTGGGCAATGTGACT TTGTTTCTCATGGACCACCA
SOD2 BC018173 AACTCAGGTCGCTCTTCAGC GCTTGATAGCCTCCAGCAAC
MT-1 NM 013602.3 CACCAGATCTCGGAA TGGAC AGGAGCAGCAGCTCT TCTTG
MT-2 NM 008630.2 TGCTCCTGTGCCTCCGATGG AGCACTTCGCACAGCCCACG
MTF-1 NM 008636.4 CCAACTCCTAACACGGCAAT TTCGATGCTTGCTGAATTTG
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Figure 1: Characterization of cadmium-induced cell death. (a) Wild-type (WT, white bars) and HIF1α−/− (black bars) cells were left
untreated (0) or exposed to 1, 2, 5, 10μM CdCl2 for 72 hours. Cell viability was assessed using a standard MTT assay. Untreated control
values within cell type were set to 1. ∗P<0.05 compared to the corresponding controls, n = 4. (b) Wild-Type (WT, solid line) and
HIF1α −/− (Null, dashed line) were left unexposed (Control, circles) or Cadmium (Cd, 5μM, triangles) for various times and cell viability
was measured using MTT assay. ∗P<0.05 compared to the corresponding controls. (c) Wild-type (WT) and HIF1α−/− cells were left
untreated (Control) or exposed to 5μM CdCl2 for 24 hours and nuclear morphology was observed after staining with Hoechst 33342 dye
using ﬂuorescence microscopy. (d) Wild-type (WT, white bars) and HIF1α−/− (black bars) cells were left untreated (Ctrl) or exposed to
CdCl2 (5μM, 24 hours), or staurosporine (1μM, 4 hours). Caspase-3 activity was measured using EnZChek caspase-3 assay kit number 2
(Molecular Probes). ∗P<0.05 compared to the corresponding controls, n = 4. #signiﬁcant compared to wild type, P<0.05, n = 4.Journal of Toxicology 5
untreated controls (Figure 1(b)). In contrast, there was no
signiﬁcant change in viability in the WT cells following
cadmium exposure.
Previously, we reported that CoCl2-induced cytotoxi-
city correlated with an increase in nuclear condensation;
however, this condensation occurred in the absence of
caspase-3 activation [20]. Under CdCl2 exposure, wild-type
and HIF1α−/− cells showed signiﬁcant levels of nuclear
condensation, characteristic of apoptosis that appears more
pronounced in the null cells (Figure 1(c)). Moreover,
HIF1α −/− MEF cells displayed much greater levels of
caspase-3 activation following cadmium exposure than the
WT cells. In contrast, the positive control, staurosporine
(an apoptosis-inducing chemical), induced similar levels
of cytotoxicity in the two cell types (Figure 1(d)). These
ﬁndings indicate that HIF1α aﬀects CdCl2-induced toxicity
in MEFs.
3.2. CdCl2 Does Not Aﬀect HIF1α Protein Levels and Tran-
scriptional Activity in MEFs. The eﬀect of cadmium on
HIF1α protein is cell line speciﬁc [23, 24]. Given that
HIF1α is primarily regulated at the level of protein stability,
theabilityofcadmiumtostabilizeHIF1α inMEFswastested
(Figure 2(a)). Unlike cobalt and nickel, cadmium treatment
did not stabilize HIF1α at any dose tested, suggesting the
metal was unable to inhibit the PHDs. HIF1α protein
levels were detected only in the wild-type cells following
CoCl2 treatment. In addition, cadmium was unable to
alter the levels of HIF1α protein in cells cotreated with
cobalt (Figure 2(a)). Previously, our group and others have
shown that the mRNA and protein levels of BNip3, a
BH3-domain-containing, cell-death-promoting factor, are
increased following cobalt chloride treatment in a HIF1α-
dependent manner [20, 25, 26]. In contrast, the BNip3
mRNA and protein levels were unaﬀected by cadmium
chloride (5μM) exposure in either cell type (Figures 2(b)
and 2(c)). These results conﬁrm our earlier observations and
suggest that cadmium-induced cell damage is not regulated
by HIF1α-mediated increases in BNip3. In addition, the
results indicate that the ability of HIF1α to protect against
cadmium-induced cytotoxicity in the WT MEFs does not
involve changes in HIF1α protein stability.
3.3. HIF1α−/− Cells Show Greater Oxidative Stress under
Cadmium Treatment. Cadmium is known to produce reac-
tive oxygen species (ROS) in various cell types [27]. Hypoxic
pre-conditioningandHIF1αtranscriptionalactivitycanpro-
tect against oxidative stress [28–30]. To begin to understand
the diﬀerence in cadmium sensitivity between the cell lines,
we probed the role of HIF1α in CdCl2-induced ROS levels
using CM-H2DCFDA. WT cells showed no change in ROS
following cadmium challenge. In contrast, exposure to cad-
mium caused a signiﬁcant increase in ROS in the HIF1α−/−
cellsasindicatedbytheshiftofmedianﬂuorescenceintensity
to the right of the black line (Figure 3(a)). The lack of a
cadmium-induced response in the WT cells was not due to
any cell-speciﬁc mechanisms, as the positive control, H2O2,
displayed a marked increase in ROS generation in the WT
MEFs. Interestingly, the HIF1α−/− cells have a higher basal
levelofROScomparedtowildtypecells(Figure 3(a)).Thisis
consistent with the observation that in the absence of HIF1α,
there is an increased ﬂux through the electron transport
chain due to the dysregulation of pyruvate dehydrogenase
kinase, leading to elevated levels of ROS [31].
To determine if the increased levels of ROS in the
HIF1α −/− cells play a role in their increased sensitivity
to cadmium-induced cytotoxicity, cell viability assays were
performed in the presence of various scavengers. N-acetyl
cysteine (NAC), a known antioxidant, acts as a precursor
for glutathione and can protect cells against oxidative injury
caused by metals and other agents [32]. NAC prevented
metal-induced cell damage in both WT cells and HIF1α −/−
MEF cells (Figure 3(b)). Given NAC’s ability to chelate
heavy metals, such as cadmium, other antioxidants were
also tested. In both cell types, reduced glutathione oﬀered
protection from cadmium-induced reduction in viability
(Figure 3(c)). The level of protection was much more
modest,butsigniﬁcant,intheWTcells.Oxidizedglutathione
did not protect the wild-type cells, however, there was a
slight but statistically signiﬁcant protection in the null cells
(Figure 3(d)). Melatonin, a natural antioxidant, also pro-
tected both cell types against cadmium treatment, although
to a lesser degree (Figure 3(e)). Interestingly, ascorbic acid
did not protect either cell type against cadmium-mediated
cell injury (Figure 3(f)). These results point to the roles
of increased ROS and oxidative stress as explanations for
the increased cadmium-induced cytotoxicity in HIF1α −/−
MEFs.
3.4. HIF1α Aﬀects Metallothionein and Metal Transcription
Factor-1 Protein Levels upon CdCl2 Exposure. Given metal-
lothioneins’ role as transporters of bioavailable cadmium
and zinc, it was important to determine if changes in their
levels could explain the diﬀerence in cadmium sensitivity
between the two cell types [33, 34]. Metallothioneins
have also been shown to be induced by cadmium as
an adaptive response to protect against toxicity from the
metal [35, 36]. It is also known that hypoxia induces
the expression of metallothionein through its ability to
induce Metal Transcription Factor-1 (MTF-1) binding to
metal response elements [37, 38]. We measured the mRNA
levels of Metallothionein-1 (MT-1), Metallothionein-2 (MT-
2), and MTF1. Both cell types showed a robust increase
in MT-1 and MT-2 expression upon cadmium exposure
(Figures4(a)and4(b)).Eventhoughthecadmiumtreatment
induced MT-1 and MT-2 in both cell types, there was
a signiﬁcant 30 and 45% reduction in the mRNA levels
of MT-1 and MT-2 in the control and cadmium-treated
samples of the HIF1α −/− cells compared to wild-type cells,
respectively (Figures 4(a) and 4(b)). Cadmium treatment
reduced MTF-1 mRNA levels in wild-type and HIF1α −/−
cells (Figure 4(c)). We also measured the protein levels of
MT-1/2 (the antibody could not distinguish between the
two isoforms) and MTF-1. Wild-type and HIF1α −/− cells
had undetectable levels of MT-1/2 protein in the control
samples (Figure 4(d), middle panel). CdCl2 exposure led6 Journal of Toxicology
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Figure 2: Hypoxia signaling and cytotoxicity to CdCl2. (a) Wild-type (WT) cells were left untreated (Ctrl) or exposed to 150μMC o C l 2
(Co2+), 1, 5 or 10μM CdCl2 (Cd2+)o r1 5 0μMC o C l 2 and 10μM CdCl2 for 24 hours. HIF1α−/− cell extract treated with 150μMC o C l 2 was
used as a negative control. Nuclear protein was extracted and separated by SDS-PAGE, transferred to nitrocellulose membrane and probed
with a HIF1α (upper panel) or β-actin (lower panel) speciﬁc antibody. The bands observed in the cadmium only WT cells are nonspeciﬁc
as they are also observed in the HIF1α−/− cells. (b) BNip3 mRNA expression levels were analyzed by qRT-PCR in wild type (WT, white
bars) and HIF1α−/− cells (black bars). Cells were left untreated (0), or exposed to 5μM CdCl2 (Cd2+)o r1 5 0μMC o C l 2 (Co2+) for 24 hours.
Each value was normalized to the control level in the corresponding cell line. ∗P<0.05 compared to the corresponding controls, n = 4. (c)
BNIP3 protein levels were determined in wild type and HIF1α−/− cells after treatment with 150μMC o C l 2 (Co2+)o r5μM CdCl2 (Cd2+)
for 24 hours using a BNIP3 speciﬁc antibody and β-actin was used as a loading control (lower Panel).
to a large increase in metallothionein protein in WT cells.
There was also an induction of metallothionein protein in
the HIF1α −/− cells following cadmium challenge, however,
this increase was much less than that of the WT cells
(Figure 4(d)). The decreased MT-1/2 protein expression in
the HIF1α −/− compared to WT metal-treated cells conﬁrm
the decreased mRNA levels (Figures 4(a), 4(b),a n d4(d)).
MTF-1 protein levels were also markedly greater in the wild-
type cells compared to HIF1α −/− cells in both control and
cadmium-treated samples (Figure 4(d), lower panel). The
protein levels, however, did not change between controls and
treated samples in either cell type. The above results indicate
that HIF1α plays a major role in maintaining the basal
levels of MTF-1 and in regulating the cadmium-induced
metallothionein protein levels and might indicate a possible
mechanism for the increased ROS and cadmium-induced
cytotoxicity in HIF1α −/− cells.
3.5. Superoxide Dismutase Levels in CdCl2-Treated Cells.
CdCl2 exposurehasbeenshowntoproducesuperoxides[39].
Superoxide is rapidly removed from the cellular space by
superoxide dismutases (SODs), which convert the superox-
ide into oxygen and hydrogen peroxides [40]. To determine
if cadmium-mediated alterations in ROS are correlated with
changes in SOD expression, the mRNA levels of SOD1 and
SOD2 were analyzed by qRT-PCR. In agreement with ourJournal of Toxicology 7
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Figure 3: Oxidative Stress in CdCl2-mediated cytotoxicity. (a) Wild-type (WT) and HIF1α −/− cells were left untreated (Ctrl), or exposed
to 2mM H2O2 (H2O2, 2 hours), or 10μM CdCl2 (Cd2+, 24 hours). Reactive oxygen species generated in the cell were measured using the
ROS-sensitive dye, CH-H2DCFDA, and ﬂow cytometry. Arrow points to the median ﬂuorescence intensity of control cells. (b) Wild-type
(white bars) and HIF1α −/− (black bars) cells were treated with 10μM CdCl2 (Cd2+) alone or with 10mM N-acetyl cysteine (NAC) for 24
hours and cell viability was measured using MTT assay. (c)–(f) Wild-type (white bars) and HIF1α −/− (black bars) cells were treated with
5μM CdCl2(Cd2+) alone or with 1mM reduced glutathione (GSH, C), 1mM oxidized glutathione (GSSG, D), 0.5mM Melatonin (MEL, E),
0.2% ethanol (ETH, E) or 0.5mM ascorbic acid (Asc., F) and cell viability was measured using MTT assay. Control values within cell type
were set to 1. ∗signiﬁcant compared to cadmium treatment within each cell type, P<0.05, n>4.8 Journal of Toxicology
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Figure 4:Cadmium-inducedchangesinmetallothioneinandMTF-1.Wild-type(WT,whitebars)andHIF1α −/−(blackbars)cellswereleft
untreated (Ctrl) or 5μM CdCl2 (Cd2+) for 24 hours. Metallothionein-1 (A, MT-1), Metallothionein-2 (B, MT-2), and Metal Transcription
Factor-1 (C, MTF-1) mRNA levels were measured using qRT-PCR. All values were normalized to wild-type control. The number above each
bar is the fold change for that particular treatment. ∗P<0.05 compared to respective controls, #P<0.05 compared to wild-type cells within
treatment group, n = 6. G. Metallothionein-1/2 (middle panel) and MTF-1 (lower panel) protein levels were determined in wild-type and
HIF1α −/− cells after treatment with 5μM CdCl2 (Cd2+) for 24 hours. β-actin was used as a loading control (upper panel).
previously published report, SOD1 and SOD2 mRNA levels
were lower in the untreated HIF1α −/− cells compared to
WTcells(Figures5(a)and5(b))[6].CdCl2treatmentdidnot
alter the expression of SOD1 or SOD2 in either cell type. To
determine if these changes in mRNA expression correlated
with changes in SOD protein levels, SOD1 and SOD2 were
analyzed by Western blot analysis. In agreement with the
mRNA data, SOD1 protein levels were slightly lower in the
HIF1α −/− control cells compared to wild-type cells. Metal
exposure did not alter the levels of SOD1 in the wild-type
cells, whereas a reduction was observed in HIF1α −/− cells
(Figure 5(c)). Basal level of SOD2 protein was marginally
higher in the HIF1α −/− cells compared to WT cells. CdCl2
treatment caused a slight increase in SOD2 protein levels in
wild-type cells and there was no change in the HIF1α −/−
cells. Finally, total superoxide dismutase activity was also
consistently lower in HIF1α −/− cells compared to WT
cells (Figure 5(d)). These results suggest that HIF1α −/−
cells have a reduced capacity to cope with superoxide stress
compared to their WT counterparts and this might explain
the diﬀerence in ROS levels and susceptibility to cadmium-
induced cytotoxicity.
3.6. Eﬀect on Glutathione Levels in Cells Treated with CdCl2.
G l u t a t h i o n ep l a y sac r i t i c a lr o l ei nv a r i o u sd e t o x i ﬁ c a t i o n
reactions within the cell by acting as a reducing agent [41,
42]. Cadmium is known to deplete the cellular glutathione
pool by covalently binding to its sulfhydryl groups and
thereby compromises the cell’s ability to protect against
oxidativestress[17].Todetermineifmetalexposurecanalter
the glutathione pool within the wild-type or HIF1α −/−
cells, total cellular glutathione was assessed [43]. HIF1α −/−
cells showed higher total glutathione levels under control
conditions compared to WT cells (Figure 6(a)). Both cell
types showed an increase in total glutathione following cad-
mium exposure but the increase was statistically signiﬁcant
in the wild-type cells only. The absolute levels of total
glutathione remained higher in the HIF1α −/− cells under
control and cadmium treatment conditions. This may be
an indication of the greater demand for antioxidants in theJournal of Toxicology 9
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Figure 5: Expression and activity of superoxide dismutases. Transcript levels of SOD1 (a) and SOD2 (b) were determined using qRT-PCR
in wild-type (WT, white bars) and HIF1α −/− cells (black bars). Each value was normalized to the wild-type control levels. Cells were left
untreated (Ctrl) or treated with 5μM CdCl2 (Cd2+) for 24 hours. (c) Protein levels of both SOD1 (middle panel) and SOD2 (bottom panel)
were determined by Western blotting in wild-type (WT) and HIF1α −/− cells. β-actin levels (upper panel) were used as a loading control.
Cells were treated as in (a) and (b). (d) Total superoxide dismutase enzyme activity in wild-type (WT, white bars) and HIF1α −/− (black
bars) cells were determined. Cells were treated as in (a) and (b). #signiﬁcant compared to wild-type cells, P<0.05, n = 4.
HIF1α −/− cells due to increased oxidative stress in the
control and CdCl2 treatment conditions.
Cells under oxidative stress utilize glutathione (GSH)
to reduce the biological molecules to their native state and
in the process GSH is converted into its oxidized form,
glutathione disulﬁde (GSSG). The GSSG levels were elevated
inbothcelltypesfollowingcadmiumexposure(Figure 6(b)).
But the levels were markedly higher in the HIF1α −/−
cells compared to the wild-type cells (Figure 6(b)). This
indicates that the ratio of reduced glutathione to total
glutathione is much lower in the HIF1α −/− cells under
CdCl2 treatment compared to wild-type cells. This decreased
level of reduced glutathione will compromise the cell’s ability
to cope with oxidative damages to the cellular organelles and
biomolecules (Figures 6(a) and 6(b)).
3.7. Elevated Lipid Peroxidation in HIF1α −/− Cells Treated
withCdCl2. Cadmiumisknowntoinducelipidperoxidation
in cells [27, 44]. The cellular consequence of the increased
ROS levels and the decreased scavenging capacity was
determined by analyzing the levels of lipid peroxidation of
the two cell types in the presence and absence of cadmium.
One measure of lipid peroxidation is the production of mal-
ondialdehyde (MDA) which is formed by the decomposition
of lipid hydroperoxides of polyunsaturated fatty acids. MDA
levelswereelevatedintheHIF1α −/−controlcellscompared
to the wild-type cells (Figure 7). This is in agreement with
the increased ROS levels in the null cells (Figure 3(a))a n d
decreased SOD activity (Figure 5(d)). Most interestingly,
the MDA levels were extremely high in the CdCl2-treated
HIF1α −/− cells, suggesting massive lipid peroxidation and
resulting damage to biomolecules. The hydrogen peroxide-
treated cells showed elevated MDA levels in both cell types
(Figure 6). Taken in sum, the results indicate that HIF1α
plays a major role in protecting cells against cadmium-
induced oxidative stress.10 Journal of Toxicology
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Figure 6: Cellular glutathione levels under CdCl2 treatment. Total cellular glutathione levels (a) and reduced glutathione levels (b) in wild-
type(WT,whitebars)andHIF1α −/−(blackbars)cellsweredetermined.Cellswereleftuntreated(Ctrl),ortreatedwith5μMCdCl2 (Cd2+)
for 24 hours. ∗P<0.05 compared to respective controls, n = 4. #P<0.05, signiﬁcant compared to wild-type cells, n = 4.
4. Discussion
Cell signaling pathways in eukaryotic cells were developed
through evolution for meeting cellular needs. It is not
uncommon to see a single signaling pathway participating
in disparate biological processes. The evolution of hypoxia
signaling pathways to mediate a response to hypoxia was
the result of transition from an anaerobic to an aerobic
environment. This change in environment facilitated the
development of an electron transport chain, increasing the
cellular energy production. This oxygen-dependent energy
production,however,increasedthesusceptibilitytooxidative
damage, through the production of ROS. It is not surprising
that nature evolved a signaling system that has a dual role of
maintainingenergylevelsfollowinglossofoxygentension,as
well as protection against oxidative stress such as the hypoxia
signaling pathway. HIF1 plays a central role in maintaining
ATP levels following loss of oxygen tension by increasing
the glycolytic capacity of the cells [45]. HIF1 also regulates
the expression of various genes involved in protecting cells
against oxidative stress. Hypoxia induces the expression of
erythropoietin,NQO1,HO-1,heatshockproteins,andother
factors that are involved in the cell survival as well as
detoxiﬁcation of ROS [46–48]. HO-1 and NQO-1 are also
induced by heavy metal exposure and are thought to play a
protective role in metal induced toxicity [49].
In this study, we investigated the role of HIF1α in mod-
ulating cadmium-induced cytotoxicity. The results demon-
strate that HIF1α −/− cells are more sensitive to cadmium-
induced toxicity. This is in contrast to the cobalt-induced
toxicity, which is more toxic to wild-type MEFs. Presumably,
this diﬀerence is due, in part, to each metal’s ability to inhibit
PHDs and thus regulate HIF1α stability [20]. Cobalt is
capableofstabilizingHIF1α anditpromotesHIF1-mediated
transcription. In contrast, cadmium treatment does not
inhibit the PHDs and lead to HIF1α stabilization nor was
it able to drive the expression of hypoxia-regulated genes.
These results are in agreement with previously published
reports [23]. Cadmium was also unable to inhibit cobalt-
induced HIF1α stabilization. This is in contrast to the result
observed in Hep3B cells where cadmium was able to inhibit
hypoxia-induced HIF1α stabilization [24]. This disparity is
probably due to the diﬀerent treatments and cell types.
Under cadmium exposure, wild-type and HIF1α −/− cells
undergo apoptosis, characterized by caspase activation and
chromatin condensation, independent of BNIP3 expression.
Interestingly, cadmium-induced changes in caspase-3 activ-
ity and nuclear condensation were more pronounced in the
HIF1α −/− cells.
Metallothioneins are the major transporters and storage
proteins of cadmium in cells. HIF1α and metallothioneins
have been shown to have a reciprocal relationship. Metal-
lothionein overexpression has been shown to inﬂuence HIF
signaling and HIF1α plays a role in the expression of met-
allothioneins, especially under hypoxia [37, 38]. Our group
has shown that basal MT-1 mRNA levels are dependent
on HIF1α in MEFs (Supplementary Table H in [6]). The
partial dependence of metallothionein mRNA and protein
onHIF1αmaybeduetochangesinMTF1orotherunknown
metallothionein regulatory protein(s) whose expression is
inﬂuenced by HIF1α. For example, the basic helix-loop-
helix-leucine zipper protein, USF (upstream stimulatory
factor family), plays a dominant role on induction of
metallothionein transcription following cadmium and H2O2
exposure [50]. USF associates with an unknown protein
that binds to an antioxidant response element that overlaps
with the USF-binding site (USF/ARE), in the mouse MT-
1 promoter. If USF or its partner protein is inﬂuenced
by HIF1α levels is unknown [50]. There is evidence for
a cooperative role of HIF1α and USF in mediating gene
regulation. In primary rat hepatocytes, hypoxic induction
of glucokinase is mediated by binding of HIF1α and USF-
2a to a common binding site in the promoter region [51].
There is also evidence for MTF-1-independent induction ofJournal of Toxicology 11
metallothionein by cadmium exposure. In IMR-32 human
neuroblastoma cells, cadmium has been shown to induce
MT-1 expression independent of MTF-1 and zinc [52].
We also show that MTF1 protein expression is inﬂuenced
by HIF1α even though their levels do not change upon
cadmium treatment (Figure 4(d)). Whether this is a direct
or indirect response is not clear. MTF1 is known to be
regulated at the posttranslational level by cytoplasmic-
nuclear traﬃcking which is supposed to involve other signal
transduction pathways such as kinases and phosphatases
[53, 54]. This might partly explain the discordance in mRNA
and protein levels of MTF1 and metallothionein levels in
these cells.
Another important characteristic of cadmium exposure
was increased ROS levels in the HIF1α −/− cells compared
to wild-type cells. Redox active metals such as iron, cobalt,
and nickel are thought to produce ROS through Fenton-
like reactions. In contrast, redox inactive metals such as
mercury and cadmium are thought to deplete cellular
sulfhydryl antioxidant reserves and interfere with cellular
antioxidant enzymes, such as glutathione transferases and
glutathione peroxidases, leading to oxidative stress [17, 55].
In these experiments, cadmium was capable of producing
much higher ROS levels in HIF1α −/− cells. Interestingly,
untreated HIF1α −/− cells had a much higher level of
ROS compared to the wild-type cells (Figure 3(a)). Similar
results in MEF cells were observed by a number of groups,
including Kim et al., who found an increased production of
H2O2 in HIF1α −/− cells compared to wild-type MEFs [31].
Their data suggest that HIF1α −/− MEF cells have lower
levels of pyruvate dehydrogenase kinase1 (PDK1), a key
inhibitory enzyme for the pyruvate dehydrogenase complex.
This complex regulates the ability of pyruvate to enter the
mitochondria. The authors conclude that increased carbon
ﬂux through the tricarboxylic acid cycle (TCA cycle), due
to loss of PDH inhibition and subsequent electron ﬂow
through the ETC in HIF1α −/− cells, leads to increased
oxidative stress. Our data also suggest that the most eﬀective
method to counter cadmium toxicity is to increase the
glutathione reserves by treating with reduced glutathione or
N-acetyl cysteine (NAC), a precursor for glutathione, which
is consistent with many other studies [56, 57]. Melatonin,
which has been shown to help in the maintenance of cellular
reduced glutathione pool as well as modulate the cadmium-
induced expression of metallothionein-2a, was also capable
of partially protecting the cells against cadmium insult [58,
59]. These results are consistent with the observations of Im
et al. [56]. They saw that in primary cortical glia cell cultures
NAC and reduced glutathione protected against cadmium-
mediated injury whereas ascorbate or oxidized glutathione
did not, indicating the role of glutathione depletion in
causing the injury.
Oxidative stress can be a result of reduced elimination
of reactive species. Previous reports have demonstrated that
HIF1α −/− cells have a lower level of SOD1 and SOD2
mRNA compared to wild-type cells [6] (Figures 5(a) and
5(b)). Overall levels of SOD1 protein and total superoxide
dismutase activity were also low in the HIF1α −/− cells
compared to their wild-type counterparts. This decrease in
dismutase activity might bias the HIF1α null cells towards
cadmium-induced cytotoxicity. SOD1 is transcriptionally
regulated by the binding of NF-kB, AP-1, AP-2, C/EBPα,
SP1, EGR1, and WT1 proteins [60, 61]. NF-kB is a
major transcription factor that regulates the constitutive
and inducible expression of SOD1 and SOD2 [60]. NF-kB
activity is modulated by HIF prolyl hydroxylase enzymes
which are targets of HIF1α-mediated transcription [62].
Also, SOD2 has been demonstrated to be a HIF2 target
gene and HIF2α knockout mice have decreased SOD2 levels
coinciding with increased cellular ROS levels [63, 64]. It is
not known if HIF1α, the major isoform in MEFs, plays a
similar role in maintaining SOD2 levels. CdCl2-treatment
did not signiﬁcantly alter the expression of SOD1 in either
cell type. There was a minor reduction in protein levels in
the CdCl2 treated HIF1α −/− cells compared to untreated
controls. This is in contrast with the reports of increased
expression of SOD1 by heavy metals in transient transfection
experiments [65]. However, Thijssen et al. reported reduced
levels of SOD1 in rats exposed to chronic low dose exposure
to cadmium [49]. Another group has reported an increase in
the nuclear activity of SOD upon exposure to cadmium in a
lymphocytic cell line, whereas we saw a decrease in activity
in the wild-type cells [66]. In an in vivo r a ts t u d y ,S h u k l ae t
al. have observed strong inhibitory eﬀect on SOD activity by
cadmium exposure [67]. It is possible that cell type, dose,
and model system may determine the modulation of SODs
u p o nc a d m i u me x p o s u r e .I nt h ep r e s e n ts t u d y ,i ti sd i ﬃcult
to separate the eﬀe c t so fc h a n g e si nm R N Aa n dp r o t e i n
expression, and cadmium-induced SOD activity inhibition,
except to say that HIF1α seems to play a crucial role in
maintaining total superoxide dismutase activity.
Anothermechanismcellsusetocopewithoxidativestress
is the glutathione system. In these experiments, the cellular
glutathione pool was increased in wild-type and HIF1α −/−
cellsunderCdCl2 treatment.Thecadmium-inducedincrease
in available glutathione was only signiﬁcant in the WT cells.
Thislackofmetal-inducedincreaseinglutathionemightplay
a role in the cadmium cytotoxicity in the null cells. The
higher glutathione levels in the HIF1α −/− cells compared
to wild-type cells, in all treatments studied, may suggest an
increased demand for glutathione for a cell under oxidative
stress as indicated by elevated levels of GSSG (Figure 6). A
reduction in the level and activity of glutathione utilizing
enzymes may also result in an increased cellular glutathione
pool. We have shown earlier that mRNA levels of GSTμ1,
a major mitochondrial xenobiotic enzyme, is signiﬁcantly
lower in the HIF1α −/− cells compared to wild-type cells
[6]. The expression levels of GSTα1, another glutathione
transferase enzyme, were also lower in the HIF1α −/− cells
(data not shown). This may also have consequences in the
reactive oxidation species scavenging ability of the cells.
The end result of increased oxidative stress is biomolecular
damage. The elevated MDA levels in the HIF1α −/− cells
(Figure 7) are evidence for their inability to cope with
increased oxidative stress under CdCl2 exposure.
Taken together, our results suggest that the adaptive
response of the HIF1 signaling pathway through the induc-
tion of metallothioneins, and maintenance of a functional12 Journal of Toxicology
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Figure 7: Lipid peroxidation under CdCl2 treatment. Lipid perox-
idation levels were determined in wild type (WT, white bars) and
HIF1α −/− (black bars) by measuring malondialdehyde (MDA)
levels. Cells were left untreated (Ctrl), or treated with 5μM CdCl2
(Cd2+)for24hoursor2mMH2O2 for4hours. ∗P<0.05compared
to respective controls, n = 4. #P<0.05, signiﬁcant compared to
wild-type cells, n = 4.
and potent ROS scavenging system, protects cells against
cadmiuminsult.Thesesamefactorsmayplayasimilarrolein
protectionagainstotherROS-producingagentssuchasheavy
metals or other compounds. This study underscores the
signiﬁcant role played by HIF1α in the presence of oxygen
and its role in maintaining cellular homeostasis.
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